NuvOx Pharma Pty Ltd   Report issue

For profit Phase 1 Phase 3
Founded: Tucson AZ United States (2008)

Organization Overview

First Clinical Trial
2014
NCT02189109
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

NuvOx LLC | NuvOx Pharma Pty Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

dodecafluoropentane (3 trials)

Drugs in Phase 1 Trials (1)

nvx-508 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 1)

Glioblastoma (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 2